A Cancer-Favoring, Engineered Vaccinia Virus for Cholangiocarcinoma

While oncolytic vaccinia virus-based therapy has shown promising results for uncured patients with cancer, its effects on cholangiocarcinoma (CCA) remain unclear. Here, we evaluated the anti-cancer activity of the cancer-favoring oncolytic vaccinia virus (CVV), which was recognized as a promising th...

Descripción completa

Detalles Bibliográficos
Autores principales: Yoo, So Young, Badrinath, Narayanasamy, Lee, Hye Lim, Heo, Jeong, Kang, Dae-Hwan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6896061/
https://www.ncbi.nlm.nih.gov/pubmed/31717883
http://dx.doi.org/10.3390/cancers11111667

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6896061/
https://www.ncbi.nlm.nih.gov/pubmed/31717883
http://dx.doi.org/10.3390/cancers11111667

Ejemplares similares